PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy

Por Luk, Sietse J, van der Steen, Dirk M, Hagedoorn, Renate S, Jordanova, Ekaterina S, Schilham, Marco W, Bovée, Judith VMG, Cleven, Arjen HG, Falkenburg, JH Frederik, Szuhai, Karoly, Heemskerk, Mirjam HM
Publicado no Oncoimmunology (2018)

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma

Por Gezgin, Gülçin, Luk, Sietse J., Cao, Jinfeng, Dogrusöz, Mehmet, van der Steen, Dirk M., Hagedoorn, Renate S., Krijgsman, Daniëlle, van der Velden, Pieter A., Field, Matthew G., Luyten, Gregorius P. M., Szuhai, Karoly, Harbour, J. William, Jordanova, Ekaterina S., Heemskerk, Mirjam H. M., Jager, Martine J.
Publicado no JAMA Ophthalmol (2017)